Biosuperior technology inc
WebFind company research, competitor information, contact details & financial data for Biosuperior Technology, Inc. of Los Altos, CA. Get the latest business insights from … WebJun 17, 2024 · Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 1. Total Funding Amount $256K. Lead Investors 1. Investors 1. ... BioSuperior has raised a total of $256K in funding over 1 round. This was a Grant round raised on Jun 17, 2024. Which funding types raised the most money?
Biosuperior technology inc
Did you know?
WebBioSuperior Technology, Inc. n/a. Founded date unknown. USA. BioSuperior Technology, Inc. helps biotechnology and pharmaceutical companies to develop novel drugs by optimizing drug formulation and structure to enhance efficacy, safety and other properties that affect product performance. WebMay 21, 2024 · MILPITAS, Calif. – AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody. CD47 is a “don’t eat me” signal that is over expressed on cancer …
WebDec 28, 2024 · AbVision, Inc., an innovative biopharmaceutical company, has developed two novel bispecific therapeutic antibody candidates: AVI-525B and AVI-535B, powered by its SpeedyAb™ technology platform of therapeutic antibody. CD47 is a “don’t eat me” signal that is over expressed on cancer cells and enables cancer cells to escape … WebApr 7, 2024 · NEW YORK, NY, USA I April 05, 2024 I Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the first patient has been …
http://abvisioninc.com/2024/05/15/biosuperior-anti-cd47-therapeutic-antibody-avi-105/
WebOperating Status Active. Last Funding Type Grant. Legal Name BioSuperior Technology, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number …
WebBIOSUPERIOR TECHNOLOGY, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 1731 Penny Way Los Altos, CA 94024: Registered Agent: Russ Lehrman: Filing Date: April 05, 2024: File Number: 4261048: Contact Us About The Company Profile For Biosuperior Technology, Inc. chinese consulate app downloadWeb1 day ago · FPI-2068 is a targeted alpha therapy (TAT) designed to deliver actinium-225 to various solid tumors that express EGFR and cMET. EGFR and cMET are both validated targets that are co-expressed in multiple tumor types, including head and neck squamous cell carcinoma, non-small cell lung cancer, colorectal cancer, and pancreatic ductal … grand forks empire theaterWebBioSuperior Technology, Inc. is testing the waters to evaluate investor interest. No money or other consideration is being solicited; if sent, it will not be accepted. No offer to buy … chinese consulateWebXencor's lead biosuperior compound is an anti-TNF antibody engineered using the company's proprietary Xtend™ antibody engineering technology for increasing antibody half-life. Xencor expects to initiate a Phase 1 trial in 2013 potentially resulting in key human pharmacokinetic data validating Xtend technology. About Xencor, Inc. chinese consulate aucklandWebOct 20, 2024 · President & Founder at BioSuperior Technology, Inc. - Creating Novel Biotherapeutics Los Altos, California, United States. 1K … chinese consulate auckland visa applicationWebBioSuperior is a preclinical stage biotherapeutics firm that develops technologies to cure lung disease and repair damaged lung tissue. Search Crunchbase. ... BioSuperior uses … chinese consulate auckland new zealandWebApr 3, 2014 · The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal ... chinese consulate auckland opening hours